glp-1 vision Medications and NAION: What Patients Should Know About Sudden Loss Vision loss risks in patients

Finally, publication bias cannot be excluded, especially given the increasing clinical interest in GLP-1RAs and the greater likelihood of publishing studies with favorable outcomes

A non-significant reduction in coronary plaque volume, decrease in liquid plaque volume, and a decrease in non-HDL cholesterol was observed in the sitagliptin group [81]

Given their increasing use, understanding their broader metabolic effectsincluding potential impacts on bone healthhas become an important area of clinical and research interest

Should you ever need help with your B12/MIC dosage, or if youre curious about adding B12/MIC to your regimen, were always a tap or click away

doi: 10.1176/appi.ajp.162.8.1423 109 O'ConnorR